PCR Spawns A New 'Copycat' Industry For Science

The battle over the extent of Cetus Corp.’s right to claim royalties on products resulting from the use of the company’s patented DNA amplification technology hasn’t kept other entrepreneurial companies from pursuing their piece of the PCR profit pie. Indeed, the explosive demand for this technology—some analysts estimate that by the year 2000 the market for DNA amplification tools will be as high as $1.5 billion—has spawned science s newest copycat industry. Muc


Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

The battle over the extent of Cetus Corp.’s right to claim royalties on products resulting from the use of the company’s patented DNA amplification technology hasn’t kept other entrepreneurial companies from pursuing their piece of the PCR profit pie. Indeed, the explosive demand for this technology—some analysts estimate that by the year 2000 the market for DNA amplification tools will be as high as $1.5 billion—has spawned science s newest copycat industry.

Much of the knowledge to undertake DNA amplification is in the public domain. The primary instrument needed is a heating block, a device common to labs. The other key ingredient is the Taq polymerase enzyme, which comes from bacteria originally found in hot springs. To perform DNA amplification, a target strand of DNA is placed in a tube in the heating block, enzyme and primers are added, and, through a series of automated heating and cooling cycles, the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide